These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 28455073

  • 21. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V, Tajber L, Corrigan OI, Healy AM.
    Mol Pharm; 2011 Apr 04; 8(2):532-42. PubMed ID: 21323367
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
    Wlodarski K, Sawicki W, Haber K, Knapik J, Wojnarowska Z, Paluch M, Lepek P, Hawelek L, Tajber L.
    Eur J Pharm Biopharm; 2015 Aug 04; 94():106-15. PubMed ID: 25998701
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Phase Behavior of Amorphous Solid Dispersions of Felodipine: Homogeneity and Drug-Polymer Interactions.
    Sarpal K, Delaney S, Zhang GGZ, Munson EJ.
    Mol Pharm; 2019 Dec 02; 16(12):4836-4851. PubMed ID: 31682129
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine.
    Konno H, Taylor LS.
    J Pharm Sci; 2006 Dec 02; 95(12):2692-705. PubMed ID: 16892209
    [Abstract] [Full Text] [Related]

  • 31. Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen.
    Miyazaki T, Yoshioka S, Aso Y, Kojima S.
    J Pharm Sci; 2004 Nov 02; 93(11):2710-7. PubMed ID: 15389669
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Development of fully amorphous dispersions of a low T(g) drug via co-spray drying with hydrophilic polymers.
    Zhao M, Barker SA, Belton PS, McGregor C, Craig DQ.
    Eur J Pharm Biopharm; 2012 Nov 02; 82(3):572-9. PubMed ID: 22922419
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers.
    Khougaz K, Clas SD.
    J Pharm Sci; 2000 Oct 02; 89(10):1325-34. PubMed ID: 10980507
    [Abstract] [Full Text] [Related]

  • 39. Mechanism of amorphous itraconazole stabilization in polymer solid dispersions: role of molecular mobility.
    Bhardwaj SP, Arora KK, Kwong E, Templeton A, Clas SD, Suryanarayanan R.
    Mol Pharm; 2014 Nov 03; 11(11):4228-37. PubMed ID: 25325389
    [Abstract] [Full Text] [Related]

  • 40. Characteristics of hydrogen bond formation between sugar and polymer in freeze-dried mixtures under different rehumidification conditions and its impact on the glass transition temperature.
    Imamura K, Asano Y, Maruyama Y, Yokoyama T, Nomura M, Ogawa S, Nakanishi K.
    J Pharm Sci; 2008 Mar 03; 97(3):1301-12. PubMed ID: 17683061
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.